The eatertainment brand saw same-store sales fall 7.7% last quarter, and failed to maintain a leverage ratio required by a financing covenant.

BTIG raised the firm’s price target on Guardant Health (GH) to $60 from $55 and keeps a Buy rating on the shares after its Q4 earnings beat and ...

BTIG analyst Marie Thibault raised the firm’s price target on iRhythm (IRTC) to $135 from $120 and keeps a Buy rating on the shares after its ...

When we spoke three years ago, your research was focused on the shopping center, net lease and health care subsectors. Is there anything new or different about your coverage universe here in 2025? Mr.

Wall Street is gearing up for another wave of blank check companies from seasoned and first-time sponsors, showing the ...

BTIG lowered the firm’s price target on NeoGenomics (NEO) to $17 from $18 and keeps a Buy rating on the shares. Q4 results came in light “at an ...

When U.S. investors return from the long weekend they will be faced with a stock market looking well-positioned to break out to fresh record highs. But any such move into virgin territory may precede ...